HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James Cassidy Selected Research

N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugate

6/2009Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James Cassidy Research Topics

Disease

13Colorectal Neoplasms (Colorectal Cancer)
04/2014 - 03/2002
13Neoplasms (Cancer)
11/2013 - 11/2002
4Neutropenia
05/2013 - 02/2004
2Breast Neoplasms (Breast Cancer)
11/2013 - 06/2009
2Peripheral Nervous System Diseases (PNS Diseases)
11/2013 - 05/2013
2Colonic Neoplasms (Colon Cancer)
09/2013 - 01/2012
2Lymphatic Metastasis
11/2002 - 03/2002
1Testicular Neoplasms (Testicular Cancer)
11/2013
1Thromboembolism
05/2011
1Hemorrhage
05/2011
1Chronic Obstructive Pulmonary Disease (COPD)
10/2010
1Breast Cancer 3
06/2009
1Ovarian Epithelial Carcinoma
01/2006
1Ovarian Neoplasms (Ovarian Cancer)
01/2006
1Alcoholism (Alcohol Abuse)
04/2003
1Rectal Neoplasms (Rectal Cancer)
11/2002

Drug/Important Bio-Agent (IBA)

10Fluorouracil (Carac)FDA LinkGeneric
05/2013 - 03/2002
3Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2013 - 05/2008
3NF-kappa B (NF-kB)IBA
05/2010 - 04/2003
3Pharmaceutical PreparationsIBA
04/2003 - 03/2002
2Leucovorin (Folinic Acid)FDA Link
05/2013 - 11/2010
2Bevacizumab (Avastin)FDA Link
05/2011 - 05/2010
2DNA (Deoxyribonucleic Acid)IBA
01/2008 - 11/2004
2Paclitaxel (Taxol)FDA LinkGeneric
01/2006 - 11/2005
2Thymidylate SynthaseIBA
08/2005 - 03/2002
2Proteins (Proteins, Gene)FDA Link
11/2002 - 03/2002
1figitumumabIBA
04/2014
1Sodium Glutamate (Accent)IBA
09/2013
1Sorafenib (BAY 43-9006)FDA Link
05/2013
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
08/2012
1Poly(ADP-ribose) Polymerase InhibitorsIBA
08/2012
1olaparibIBA
08/2012
1Topotecan (Hycamtin)FDA LinkGeneric
08/2012
1AnticoagulantsIBA
05/2011
1vinyltriethoxysilane (VTES)IBA
05/2011
1ErbB Receptors (EGF Receptor)IBA
11/2010
1Panitumumab (Vectibix)FDA Link
11/2010
1Monoclonal AntibodiesIBA
11/2010
1PowdersIBA
10/2010
1Glucose (Dextrose)FDA LinkGeneric
10/2010
1Insulin (Novolin)FDA Link
10/2010
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2010
1triptolideIBA
05/2010
1AnthracyclinesIBA
06/2009
1N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugateIBA
06/2009
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2009
1PolymersIBA
06/2009
1SolutionsIBA
10/2008
1Bromodeoxyuridine (BrdU)IBA
01/2008
1NucleotidesIBA
01/2008
1Propidium (Propidium Iodide)IBA
01/2008
1XELOXIBA
05/2007
1UridineIBA
05/2007
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2006
1Cisplatin (Platino)FDA LinkGeneric
01/2006
1((S)- 2- (5- (1,2- dihydro- 3- methyl- 1- oxobenzo(f)- quinazoline- 9- yl)methyl)amino- 1- oxo- 2- isoindolynyl)- glutaric acidIBA
08/2005
1Platinum Compounds (Compounds, Platinum)IBA
02/2004
1BBR 3464 (BBR3464)IBA
02/2004
1Disulfiram (Antabuse)FDA Link
04/2003
1cerivastatin (Kazak)FDA Link
11/2002
1Antineoplastic Agents (Antineoplastics)IBA
11/2002
1trioctyl phosphine oxide (TOPO)IBA
11/2002
1Proliferating Cell Nuclear Antigen (PCNA)IBA
11/2002
1Type I DNA Topoisomerases (Topoisomerase I)IBA
11/2002

Therapy/Procedure

10Therapeutics
04/2014 - 02/2004
6Drug Therapy (Chemotherapy)
11/2013 - 03/2002